Speaker illustration

Mrs Florence Joulain

Sanofi, Paris (France)

Quantifying the residual risk of cardiovascular events in secondary prevention patients with uncontrolled LDL-C receiving statins

Event: ESC CONGRESS 2016

Topic: Health economics and comparative effectiveness research

Session: Computer modelling and simulation / Big data

Thumbnail

ESC 365 is supported by

logo Novo Nordisk